HeartSciences Inc.
Income Statement
| Line Item | Jul 2022 | Jan 2022 | Jul 2021 |
|---|---|---|---|
| Revenue | $3.2K | $2.7K | $7.5K |
| Cost of Revenue | $2.0K | $854 | $5.8K |
| Gross Profit | $1.2K | $1.9K | $1.7K |
| Gross Margin | 36.4% | 68.8% | 23.1% |
| Operating Expenses | |||
| Research & Development | $434.2K | $699.0K | $401.1K |
| SG&A Expense | $997.1K | $403.2K | $275.1K |
| Operating Income | $-1.4M | $-1.1M | $-674.4K |
| Operating Margin | -44,690.5% | -40,156.5% | -9,011.8% |
| Interest Expense | $143.6K | $139.1K | $77.6K |
| Pretax Income | — | — | — |
| Income Tax Expense | — | — | — |
| Net Income | $-1.6M | $-1.2M | $-501.9K |
| Net Margin | -49,165.7% | -45,200.8% | -6,705.7% |
| EPS (Basic) | $-0.01 | $-0.01 | $0.00 |
| EPS (Diluted) | $-0.01 | $-0.01 | $0.00 |
| Shares Outstanding (Basic) | 203.2M | 119.6M | 119.3M |
| Shares Outstanding (Diluted) | 203.2M | 119.6M | 119.3M |
| Dividends Per Share | — | — | — |